Why govt banned 16 fixed-dose combination drugs, from antibiotics to aloe vera creams

📌 Summary:

• The government banned 16 fixed-dose combination (FDC) drugs — including certain antibiotic combinations and dermatological products with aloe vera and herbal ingredients — because their claimed benefits lack scientific justification.

• An FDC contains two or more active ingredients in one formulation; a combination is "irrational" when there is little or no evidence the ingredients work better together than separately.

• Public-health risk: irrational combinations expose patients to unnecessary drugs, raise costs, and — for antibiotics — drive antimicrobial resistance (AMR), where microbes stop responding to medicines (flagged by ICMR's Dr Kamini Walia).

• Examples: amoxicillin + serratiopeptidase (enzyme is acid-labile, no RCT shows it improves bacterial clearance); norfloxacin + tinidazole (patients rarely have bacterial and protozoal infection together, so one drug is wasted while resistance rises); amoxicillin + clavulanic acid (clavulanic acid is useless if bacteria are not resistant).

• AMR mechanism: marketing combinations as more effective without evidence encourages unnecessary/prolonged antibiotic use, increasing selective pressure that lets resistant organisms survive and multiply.

• On aloe vera dermatological combinations: long presence in the market does not establish scientific validity; many lack robust clinical evidence.

🎯 UPSC Relevance: GS2 — health governance and drug regulation; GS3 — antimicrobial resistance as a public-health and biosecurity threat; rational use of medicines.

📝 Prelims Facts:

• FDC = fixed-dose combination; two or more active ingredients in a single dosage form.

• Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi and parasites stop responding to drugs designed to kill them.

• Serratiopeptidase is a proteolytic (protein-breaking) enzyme; it is acid-labile.

🔑 Key Term: Irrational fixed-dose combination — a multi-ingredient drug whose components lack a scientifically established rationale for being combined, offering no proven added clinical benefit over separate use.